Top stock initiations across multiple names
Jefferies, Truist, TD Cowen, BMO, Leerink, Mizuho, Blair and BAC initiated or reiterated bullish ratings on IOT, LMRI, MRVI, NVT, ORIC, RGNX, SOC, VRT and VYLR.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
30 results loaded, newest first. More results are available. The latest changes are still being indexed. Try again shortly for updated results.
IQM Quantum Stock Gains Analyst Buy Rating on AI and Supercomputing Convergence
IQM, a leader in on-premises sales, is expected to expand its advantage by leveraging the convergence of artificial intelligence and quantum computing, according to TD Cowen analyst Krish Sankar. Sankar initiated coverage with a Buy rating.
IQM Quantum Computers Initiated at Buy by TD Cowen
TD Cowen initiated coverage on IQM Quantum Computers with a Buy rating.
SpaceX's Next Big Business May Be Renting Out AI Compute
TD Cowen initiated coverage of SpaceX NASDAQ:SPCX with a Buy rating and a $200 price target, arguing that leasing terrestrial AI computing capacity will become the company's fastest-growing revenue stream. The target implies about 37% upside from Monday's closing price of $145.47. SpaceX shares wer…
TD Cowen initiates SpaceX at Buy, targets $200
TD Cowen initiated SpaceX (SPCX) at Buy with a $200 price target, expecting terrestrial AI compute leasing—supported by demand from Google and Anthropic—to become the fastest-growing business and account for the majority of revenue by 1Q27 as capacity ramps.
SpaceX Initiated at Buy by TD Cowen
Ratings actions from Benzinga: GMT) SpaceX Price Target Announced at $200.00/Share by TD CowenRatings actions from Benzinga
Versigent Q2 2026 Earnings Call Transcript
Versigent (NYSE: VGNT ) released second-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. The full earnings call is available at Summary Versigent reported double-digit
US research roundup: JP Morgan cuts Tesla target, raises Incyte target
Reuters compiled Monday analyst actions on US-listed companies, including target changes for Tesla, Incyte and Charles River Laboratories. JP Morgan also initiated coverage on Mobility Global with a neutral rating.
PagerDuty Reports Q2 2027 Results: Full Earnings Call Transcript
On Thursday, PagerDuty (NYSE: PD ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. The full earnings call is available at Summary PagerDuty reported Q2 FY27 rev
Immunovant Q1 2027 Earnings Call: Complete Transcript
On Thursday, Immunovant (NASDAQ: IMVT ) discussed first-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary Immunovant reported a quiet
Arcus Biosciences initiated as Buy by TD Cowen
Benzinga reports TD Cowen initiated coverage on Arcus Biosciences with a Buy rating.
Forgent Power Solutions Q4 2026 Earnings Call Transcript
Forgent Power Solutions (NYSE: FPS ) reported fourth-quarter financial results on Tuesday. The transcript from the company's fourth-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summ
Wall Street's Most Accurate Analysts Weigh In On 3 Utilities Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings
TD Cowen initiates Buy rating on Korsana Biosciences
Benzinga reports TD Cowen has initiated a Buy rating on Korsana Biosciences.
Wall Street's Most Accurate Analysts Spotlight On 3 Tech Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings
Faeth Therapeutics initiated at Buy by TD Cowen
Faeth Therapeutics was initiated at a Buy rating by TD Cowen.
Braveheart Bio started Buy at TD Cowen
Braveheart Bio was initiated with a Buy rating by TD Cowen.
Analysts update targets for OneSpan, Accenture, Amdocs amid high-dividend focus
For high-dividend tech names: OneSpan’s Rudy Kessinger raised his price target to $16 (Neutral); Accenture’s Bryan Bergin raised to $173 (Hold); Amdocs coverage changes include a Sector Weight start and a Stifel price-target cut to $71 (Buy).
TD Cowen initiates JMKE at Buy, $26.00 target
TD Cowen initiates coverage of JMKE with a Buy rating and a $26.00 price target.
LKFT Initiated Buy at TD Cowen
LKFT Initiated Buy at TD Cowen
BILL Holdings faces $699 million implied post-earnings swing
BILL Holdings (NYSE: BILL) reports fourth-quarter 2026 results after the close, with analysts expecting 62 cents EPS on $430.36 million of revenue and options implying a 14.34% move, about $699 million of market value.
Coherent Could Swing By $9.54 Billion After Earnings
Earnings are back in focus on Wednesday, with a -selected slate that spans precious-metals mining and AI infrastructure through optical components. With guidance and segment commentary often moving the tape as much as the headline numbers, options markets are already sketching out the size of the post-print swing, acco
Alamar Biosciences Stock Soars, CEO Says Company Is Well-Positioned to Sustain Upcoming Momentum
Alamar Biosciences Inc. (NASDAQ: ALMR ) shares are trading higher on Tuesday as the company is expanding its global partnership with the Alzheimer’s Disease Data Initiative and Gates Ventures. The proteomics company is engaged in protein detection and analysis. • Alamar Biosciences stock is approaching key resistance l
CRCL Initiated Buy at TD Cowen
CRCL initiated buy with $82 price target
TD Cowen Initiated Buy
TD Cowen initiated buy
YARW Initiated Buy at TD Cowen
YARW Initiated Buy at TD Cowen
SpaceX initiated, PayPal upgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled. Top 5 Upgrades: Truist upgraded PayPal (PYPL) to Hold from Sell with a price target of $57, up from $44. While the firm continues to believe that the
CoreWeave upgraded, IBM initiated: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled. Top 5 Upgrades: Truist upgraded CoreWeave (CRWV) to Buy from Hold with a price target of $126, down from $131. As more enterprises move toward open mo
Wall Street's Most Accurate Analysts Spotlight On 3 Utilities Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings
CODI Initiated Buy W/$12.50 PT at TD Cowen
CODI Initiated Buy W/$12.50 PT at TD Cowen